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Abstract
The last hierarchical level of cellular genome organization is the spatial arrangement of chromosomes within 
the nuclear space. Despite of high regulatory potential and functional implications, issues concerning nuclear 
organization at chromosomal level are rarely addressed because of limitations in visualizing interphase 
chromosomes. The problem is especially seen when an attempt to associate specific patterns of nuclear genome 
organization with a pathological condition is made. Fortunately, advances in molecular cytogenetics have 
provided for a solution to visualize chromosomes in interphase nuclei at molecular resolution. A study in this 
issue of BioDiscovery shows the way of how to identify interphase chromosome architecture at molecular 
resolutions and demonstrates the involvement of specific nuclear genome organization in generating a cancer-
causing chromosomal aberration (translocation between chromosomes 8 and 21 in acute myelogenous leukemia). 
Authors’ findings suggest interphase molecular cytogenetic techniques (i.e. interphase chromosome-specific 
multicolor banding or ICS-MCB) to be required to perform studies regarding nuclear genome organization at 
chromosomal level and its role in disease pathogenesis.
Background
During interphase, chromosomes occupy non-
random positions within the nuclear space. Interphase 
chromosome arrangement is considered to play significant 
role in development and disease mediated by regulation 
of genome expression and stability maintenance [1, 
2]. However, some technical limitations in analyzing 
chromosome arrangement and positioning (visualizing 
interphase chromosomes) hinder the progress in 
studying nuclear genome organization. More precisely, 
the availability to visualize either specific genomic 
loci or ambiguous chromosome territories was found 
to be insufficient for interphase cytogenetics. To solve 
this problem, a technique providing for simultaneous 
visualization of the whole chromosome and its regions 
in a given nucleus has appeared to be required [3]. 
The development of interphase chromosome-specific 
multicolor banding (ICS-MCB) has led the way towards 
the high-resolution interphase cytogenetic analysis for 
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studying chromosomal numbers, structure and spatial 
arrangement within the nucleus [4-7]. Using ICS-
MCB, chromosome architecture was evaluated in some 
tissues at “subchromosomal” resolution and specific 
positioning of chromosomal loci was shown to be linked 
to generation and behavior of rearranged chromosomes 
in interphase [8-10]. Interestingly, specific chromosome 
positioning was previously suggested to predispose 
to cancer-causing chromosomal aberrations [11]. 
Unfortunately, convincing proofs were not obtained 
because the data were usually acquired by techniques 
painting chromosome territories without an integral 
view of the whole chromosome.
The present issue of BioDiscovery reports an 
investigation of interphase chromosome architecture 
in acute myelogenous leukemia by ICS-MCB and its 
relation to causative translocation between chromosomes 
8 and 21 [10]. In the light of authors’ findings, it seems 
pertinent to pay attention to technological aspects of 
interphase molecular cytogenetics, which are important 
for interpreting data on nuclear genome organization. 
Additionally, these aspects are also significant for 
understanding how a disease can be associated 
with specific nuclear genome organization allowing 
speculations about the implications of similar studies 
for the definition of disease pathways including genetic-
environmental interactions and the development of 
molecular therapies.
Visualizing interphase chromosomes
The interphase chromosome architecture is commonly 
determined through application of FISH (fluorescence 
in situ hybridization)-based techniques. As noted 
below, interphase molecular cytogenetic techniques are 
usually applied either for analysis of specific genomic 
loci (using probes for relatively small DNA sequences 
(rarely >1Mb) comparing to the whole chromosomes) 
or for painting the whole chromosome, visualized as 
a chromosome territory (reviewed in [3]). Although 
these approaches are successfully applied for studying 
chromosomal numbers and intranuclear arrangement, 
the impossibility to identify positioning of specific 
chromosomal regions in relation to the chromosome itself 
and to other chromosomal regions significantly reduces 
the resolution of interphase chromosomal analysis [12]. 
Three dimensional (3D) FISH allowing the visualization 
of chromosomes as volume structures provides for 
examining chromosomal positioning relative to nuclear 
structures (i.e. nuclear membrane, nucleolus etc.) 
(reviewed in [13]). Alternatively, current approaches 
towards studying DNA-based structure of chromosomes 
can depict locus positioning in four dimensions 
(space and time), which is relevant not only to basic 
principles of interphase genome organization, but also 
to chromosome arrangement in cancer cells [14]. Still, 
one has to operate with data on arrangement of specific 
chromosomal loci or ambiguous chromosome territories 
without an integral view of the whole chromosome at 
molecular resolution.
ICS-MCB is an intriguing alternative to the 
aforementioned approaches, since it gives an opportunity 
to determine structure and arrangement of differentially 
painted chromosomal regions. Its application allows 
the analysis of chromosome (chromosomal loci) 
positioning in interphase and chromosomal associations 
at “subchromosomal” resolution in a given nucleus 
(for more details see [4-9]). Evidently, analyzing each 
chromosomal region is likely to provide more reliable 
information in contrast to analyzing homogenously 
painted chromosomes or a single chromosomal region. 
The article by Dr. Liehr and colleagues in this issue 
of BioDiscovery [10] continues the line of research on 
nuclear chromosome organization performed by ICS-
MCB. Again, this technique has been demonstrated 
effective for examination of interphase chromosome 
architecture. Furthermore, this state-of-the-art technique 
in combination with FISH using gene-specific probes 
has allowed authors to show the involvement of specific 
interphase chromosome organization in promoting the 
typical translocation between chromosomes 8 and 21 
leading to acute myelogenous leukemia.
Nuclear genome/chromosome 
organization and disease
Since the introduction of interphase molecular 
cytogenetics a significant effort has been made to 
provide comprehensive information about the meaning 
of nuclear genome (chromosome) organization [1-3, 
13-15]. As a result, interphase chromosome architecture 
was demonstrated to be involved in critical nuclear 
processes, which are relevant to cellular homeostasis in 
health and disease (Box 1).
Interphase chromosome architecture plays an 
important role in modulation of transcriptional activity 
through chromatin organization [15] and regulation of 
cellular and developmental pathways [16]. Therefore, it 
is not surprising that a number of diseases associated with 
genetic defects in genes encoding chromatin architecting 
and remodeling proteins [17] as well as diseases 
characterized by genome and/or chromosome instability 
(i.e. cancers) are hallmarked by alterations to spatial 
genome organization in interphase nuclei [18]. These are 
suggested to result from failure of genome maintenance 
and DNA repair machineries, which also depend on 
interphase chromosome architecture [19]. On the other 
hand, specific chromosome positioning (intermingling 
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(1) (FI) – spatial positioning of chromosomes is likely to modulate transcriptional activity of whole chromosomes and 
specific chromosomal loci;
(RD) – alterations to transcriptional activity would certainly possess an effect on cellular homeostasis;
(2) (FI) – proper spatial positioning of chromosomes is achieved through orchestrated regulation of genome stability 
maintenance and processing machineries via chromatin architecting and remodeling proteins;
(RD) – genetic defects in genes encoding key chromatin architecting and remodeling proteins are associated with 
monogenic diseases exhibiting alterations to interphase chromosome organization;
(3) (FI) – specific positioning of chromosomes and, more importantly, chromosomal loci predispose to promoting 
chromosomal rearrangements (i.e. interchromosomal translocations) in somatic cells;
(RD) – chromosome rearrangements and instability in somatic cells are one of the commonest causes of human 
pathology including almost all cancer types;
(4) (FI) – efficient DNA repair and genome stability maintenance is mediated by specific chromosome arrangement in 
interphase;
(RD) – failures to DNA repair and genome stability maintenance result in chromosome rearrangements and 
instability in somatic cells [similar to (3)];
(5) (FI) – senescent cells exhibit specific interphase chromosome architecture;
(RD) – specific interphase chromosome/genome organization is a likely element of cellular and molecular 
pathways in diseases associated with premature/accelerated/abnormal aging, representing, thereby, a possible 
target for molecular therapies.
Box 1.  Functional implications (FI) of interphase chromosome organization and its possible relevance to disease (RD).
of chromosome territories) is considered as a mechanism 
of promoting cancer-causing interchromosomal 
translocations [8, 10, 11, 18]. Furthermore, interphase 
chromosome associations (somatic pairing) seem to be 
involved in regulation of transcriptional activity within 
specific chromosomal regions including imprinted 
genomic loci, known to be linked to hereditary diseases 
and cancer [20]. Another critical process that is featured 
by specific interphase chromosome behavior is the 
programmed cell death [21]. Since this phenomenon 
is a key step in numerous pathogenic processes, a 
link between alterations to interphase chromosome 
architecture and pathological programmed cell death 
appear to exist. Finally, the expanding complexity of 
genomic landscape in senescent cells implies the change 
of nuclear genome (chromosome) organization as a 
mechanism for aging at cellular level [22]. The latter has 
been partially confirmed by direct evaluations [23].
Although several positive associations between 
specific interphase chromosome architecture and critical 
nuclear processes have been made, it is usually hard to 
come to a definite conclusion concerning pathogenic 
value of variable chromosome arrangement in interphase 
nuclei. More probably, specific interphase chromosome 
organization is rather an element of a pathogenetic 
pathway rather than a unique underlying disease cause. 
This idea is further supported by observations on diseases 
caused by mutations in genes encoding chromatin 
architecting and remodeling proteins [17] and generation 
of cancer-causing chromosomal rearrangements [18]. 
Therefore, the analysis of nuclear genome organization 
defines disease pathways being more complex than 
previously recognized and an association of abnormal 
cellular phenotype (or disease phenotype) with specific 
nuclear genome organization seems to be an important 
milestone in understanding molecular mechanisms of 
human pathology.
Spatiotemporal interphase chromosome organization 
is highly dynamic [14] and is able to be exogenously 
manipulated [24, 25]. Considering that exogenous 
influences changing interphase chromosome architecture 
are far from being completely determined [25], one can 
already speculate on possible applications of manipulating 
nuclear structure. Specific interphase chromosome 
organization can be thus defined as a dynamic element of 
a pathogenetic pathway, which can be influenced. Such 
changes would certainly have an impact on genome 
transcriptional activity and stability maintenance, 
resulting in a beneficial effect and underlying a hypothetic 
molecular mechanism for “chromosome-oriented” 
therapy. Hypothesizing a part of such roadmap to “cure” 
diseases, in which a positive association with specific 
interphase chromosome/genome organization is made, 
is given in Figure 1. Nonetheless, it is to be stressed 
that these assumptions require further studies by means 
of high-resolution molecular cytogenetic interphase 
techniques and it is hard to disagree with Dr. Liehr and 
his colleagues [10] that further studies are necessary 
for delineation of interphase architecture in almost all 
diseases demonstrating abnormal chromosome behavior.
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Concluding remarks
Dr. Liehr and colleagues [10] have drawn the attention 
of BioDiscovery’s readers to the importance of studying 
interphase chromosome architecture and its associations 
with pathological conditions. Taking into account the 
interest to high-order genome organization, positive data 
seem to be required for encouraging further attempts at 
characterization of nuclear genome organization in health 
and disease. Moreover, technological performance of 
the study, which defines the value of such associations, 
demonstrates ICS-MCB as the promising method 
of choice for studying interphase chromosomes at 
molecular resolution. The anticipated success of related 
Figure 1. Hypothesizing a part of a suggested roadmap to “cure” diseases associated with specific nuclear organization: (i) according 
to current concepts in biomedicine, genomic/epigenomic changes occurring at DNA or chromatin levels (purple), which can result 
in abnormal interphase chromosome architecture, require molecular diagnosis and might be “managed” by gene therapy; (ii) nuclear 
chromosome (genome) organization (green) can be manipulated exogenously being, therefore, a target for therapies against alterations 
to interphase chromosome architecture, which are likely to be elements of disease pathways; (iii) at the cellular level (red), the 
phenotype of a cell would be corrected, if (i) and (ii) were performed successfully.
studies is highly dependent on the way how spatial 
arrangement of interphase chromosomes is determined. 
Future studies implementing ICS-MCB for evaluation of 
nuclear genome have the potential to shed light on the 
role that interphase chromosome architecture does play 
in disease.
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